Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.
View Top Employees from Innocoll Biotherapeutics| Website | http://www.innocoll.com |
| Revenue | $4 million |
| Funding | $88.5 million |
| Employees | 73 (73 on RocketReach) |
| Founded | 1985 |
| Address | 210 Carnegie Center 103, Princeton, New Jersey 08540, US |
| Phone | +353 90 648 6834 |
| Fax | +353 90 648 6835 |
| Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
| Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Pharmaceutical, Healthcare, Biotechnology, Targeted Drug Delivery, Collagen-based Technologies |
| Web Rank | 24 Million |
| Keywords | Innocoll Pharmaceutiacls, Collagen Isolation And Purification, Hernia Repair With Patch+Pipeline Products |
| Competitors | Biometrix, Heron Therapeutics, Inc., Osmotica Pharmaceutical Argentina S.A., PolyPid Ltd., Tracoe Medical GmbH |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Innocoll Biotherapeutics employee's phone or email?
Innocoll Biotherapeutics Questions
The Innocoll Biotherapeutics annual revenue was $4 million in 2024.
73 people are employed at Innocoll Biotherapeutics.
Innocoll Biotherapeutics is based in Princeton, New Jersey.
The NAICS codes for Innocoll Biotherapeutics are [3254, 32, 32541, 325].
The SIC codes for Innocoll Biotherapeutics are [283, 28].
Top Innocoll Biotherapeutics Employees
-
43
-
33
-
14
-
ViewNina Skuban
Vice President, Clinical Development, MA and PV at Innocoll Biotherapeutics
Philadelphia, PA, US32 -
35+
-
ViewBrian McGuire
Sr. Director Sales and Business Development at Innocoll Biotherapeutics
Washington Township, NJ, US25 -
3
Related Companies
